← FDATracker
HomeAdverse Events

CLARAVIS Adverse Event: Neoplasm malignant

CLARAVIS Adverse Event: Neoplasm malignant is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: CLARAVIS; Product category: Drug; Primary reaction: Neoplasm malignant.

Primary drugCLARAVIS
Product categoryDrug
Primary reactionNeoplasm malignant
All reactionsNeoplasm malignant
SeriousnessSerious
Patient outcomeUnknown
Patient sexFemale
All drugs reportedCLARAVIS
Reporter countryUS
Reporter type5
Report date20140312
Report ID10004651

🔍 Search all adverse events →